Rankings
▼
Calendar
KMDA FY 2023 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$520M
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$143M
+10.2% YoY
Gross Profit
$55M
38.9% margin
Operating Income
$10M
7.1% margin
Net Income
$8M
5.8% margin
EPS (Diluted)
$0.15
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
-$2M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$355M
Total Liabilities
$111M
Stockholders' Equity
$244M
Cash & Equivalents
$56M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$143M
$129M
+10.2%
Gross Profit
$55M
$47M
+18.8%
Operating Income
$10M
$5M
+122.1%
Net Income
$8M
-$2M
+456.9%
← Q4 2022
All Quarters
Q1 2023 →